Seagen Archives - Coinspeaker

Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%

Business News, Market News, News, Stocks, Wall Street

By Tolu Ajiboye Apr 27, 2023

Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report.

Business News, Deals News, Market News, News

By Mercy Tukiya Mutanya Mar 13, 2023

Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030.

Business News, Deals News, Market News, News, Stocks

By Godfrey Benjamin Jul 7, 2022

The regulatory concerns associated with the potential deal between Merck and Seagen may attract antitrust scrutiny from regulators.